TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18419724

Group type: EXPERIMENTAL
Intervention: 35 mg of 10 mg/ml isobaric 2-chloroprocaine
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 40 mg of 10 mg/ml isobaric 2-chloroprocaine
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 50 mg of 10 mg/ml isobaric 2-chloroprocaine
Number of subjects: 64
Study: 16119354

Group type: EXPERIMENTAL
Intervention: Jittered electric stimulation pattern
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Probabilistic electric stimulation pattern
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Auditory-model-generated pulses
Number of subjects: 3

Group type: COMPARATOR
Intervention: Fixed-rate control
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Multiple-electrode stimulation
Number of subjects: 3
Study: 12105306

Group type: EXPERIMENTAL
Intervention: Intrathecal methotrexate (MTX+)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intrathecal methotrexate (MTX-)
Number of subjects: 0
Study: 11794431

Group type: EXPERIMENTAL
Intervention: Tibolone 1.25 mg once/day for 7 days
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg once/day for 7 days
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Tibolone 5.0 mg once/day for 7 days
Number of subjects: 27
Study: 9724142

Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: H2-receptor antagonists
Number of subjects: 534

Group type: COMPARATOR
Intervention: Control
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Helicobacter pylori positive
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Female gender and hypergastrinemia
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Atrophic gastritis
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Long-term omeprazole treatment
Number of subjects: 534
Study: 8040761

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) at a dosage of 0.5 U/kg per week (group 1: 4 boys, 3 girls)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) at a dosage of 1.0 U/kg per week (group 2: 6 boys, 2 girls)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Both groups (0.5 U/kg and 1.0 U/kg)
Number of subjects: 15
Study: 2647038

Group type: EXPERIMENTAL
Intervention: Standard return to full milk feeds
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Immediate full strength feeds with HN25 formula
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Immediate full strength feeds with SMA Gold Cap formula
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Immediate full strength feeds with Formula S
Number of subjects: 200

Group type: COMPARATOR
Intervention: Graded return to full feeding
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 200
Study: 29847836

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 28397527

Group type: EXPERIMENTAL
Intervention: Conditional food and cash incentives
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 26224500

Group type: EXPERIMENTAL
Intervention: Personalized feedback and referral to the occupational physician (N = 207)
Number of subjects: 413

Group type: COMPARATOR
Intervention: Screening without feedback and unrestricted access to usual care (N = 206)
Number of subjects: 413
Study: 23147552

Group type: EXPERIMENTAL
Intervention: Portable robotic brace (Myomo) during repetitive task‐specific practice
Number of subjects: 16

Group type: COMPARATOR
Intervention: Manual repetitive task‐specific practice
Number of subjects: 16
Study: 20837371

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg plus ezetimibe 10 mg
Number of subjects: 2

Group type: COMPARATOR
Intervention: Atorvastatin up-titration (40 mg to 80 mg or 20 mg to 40 mg)
Number of subjects: 2
Study: 19085729

Group type: EXPERIMENTAL
Intervention: Preoperative CT scan for measuring posterior condylar angle in group b.
Number of subjects: 57

Group type: COMPARATOR
Intervention: Surgeon's own method with a posterior condylar angle of three degrees of external rotation in group a.
Number of subjects: 57

Group type: COMPARATOR
Intervention: Comparison of femoral malrotation degrees between groups.
Number of subjects: 57
Study: 16181608

Group type: EXPERIMENTAL
Intervention: Individually tailored behavioral medicine treatment
Number of subjects: 82

Group type: COMPARATOR
Intervention: Physical exercise therapy
Number of subjects: 82
Study: 12848301

Group type: EXPERIMENTAL
Intervention: AIDA diabetes simulator
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional lessons with slides and transparencies (Control Group B)
Number of subjects: 24
Study: 11468787

Group type: EXPERIMENTAL
Intervention: No previous treatment to eradicate the infection
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Previous eradication therapies
Number of subjects: 117

Group type: COMPARATOR
Intervention: Amoxicillin
Number of subjects: 117
Study: 9196518

Group type: EXPERIMENTAL
Intervention: BAYx 1005 (500 mg twice daily)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 1436339

Group type: EXPERIMENTAL
Intervention: r‐HuEPO administered intravenously
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: r‐HuEPO administered subcutaneously
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: r‐HuEPO (both intravenous and subcutaneous)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: r‐HuEPO
Number of subjects: 20
Study: 31107119

Group type: EXPERIMENTAL
Intervention: Comprehensive mental health and psychosocial support services at Saftawi Health Center
Number of subjects: 408

Group type: COMPARATOR
Intervention: Control group receiving standard care at Nasser Health Center
Number of subjects: 408
Study: 28268084

Group type: EXPERIMENTAL
Intervention: Heart failure duration <1 year
Number of subjects: 0

Group type: COMPARATOR
Intervention: Heart failure duration >5 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Age influence on BNP concentration
Number of subjects: 0
Study: 26272324

Group type: EXPERIMENTAL
Intervention: Antimicrobial stewardship program (ASP) utilizing prospective chart audit and feedback
Number of subjects: 339

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: Antimicrobial stewardship program (ASP)
Number of subjects: 339
Study: 23945376

Group type: EXPERIMENTAL
Intervention: Artemisinin-combination therapy (ACT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Residual parasitemia
Number of subjects: 0
Study: 21346060

Group type: EXPERIMENTAL
Intervention: GIN therapy (n = 49)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Standard metabolic care (control, n = 50)
Number of subjects: 99
Study: 19656386

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care support programme in primary care
Number of subjects: 194

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 194
Study: 16407807

Group type: EXPERIMENTAL
Intervention: Tramadol plus ketorolac
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tramadol alone
Number of subjects: 60
Study: 14757609

Group type: EXPERIMENTAL
Intervention: Intervention group (7-session program designed to reduce television viewing)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (safety and injury prevention program)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Adjusted difference between groups
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Adjusted difference in percentage of children watching more than 2 h/d
Number of subjects: 16
Study: 12666948

Group type: EXPERIMENTAL
Intervention: Braun Oral-B 3D Plaque Remover (three-dimensional oscillating/rotating/pulsating action)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sonicare Plus (high-frequency vibrating action)
Number of subjects: 33
Study: 9144030

Group type: COMPARATOR
Intervention: D-dimer plasma levels during period A (7-20 weeks)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: D-dimer plasma levels during periods B and C (21-30 weeks and > 30 weeks)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Fibrinogen levels during period A (7-20 weeks)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Fibrinogen levels during periods B and C (21-30 weeks and > 30 weeks)
Number of subjects: 63
Study: 8188397

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (2 grams per day)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 3309021

Group type: EXPERIMENTAL
Intervention: Psychological counseling
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo cimetidine
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Maintenance cimetidine (400 mg at bedtime)
Number of subjects: 148
Study: 29493475

Group type: EXPERIMENTAL
Intervention: Cleansing skin of one forearm with no-rinse 2% CHG-impregnated polyester cloth (method A)
Number of subjects: 63

Group type: COMPARATOR
Intervention: 4% CHG liquid cleansing with rinsing on the contralateral arm, applied with non-antiseptic-impregnated cellulose/polyester cloth (method B)
Number of subjects: 63

Group type: COMPARATOR
Intervention: 4% CHG liquid cleansing with rinsing on the contralateral arm, applied with cotton washcloth dampened with sterile water (method C)
Number of subjects: 63
Study: 26585596

Group type: EXPERIMENTAL
Intervention: REVEAL(®)XT implantable cardiac monitors (ICMs)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Permanent pacemakers (PPMs) programmed to monitoring only (ODO)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Negative predictive value for the absence of all AF
Number of subjects: 50
Study: 24491073

Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 104

Group type: COMPARATOR
Intervention: Medications
Number of subjects: 104
Study: 22578110

Group type: EXPERIMENTAL
Intervention: NSAID (rofecoxib 50 mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 20947859

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF) at doses of 30-180 μg/kg over 3 days
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF)
Number of subjects: 44
Study: 18958985

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 33
Study: 16900709

Group type: EXPERIMENTAL
Intervention: Nephrostomy tube (NT) and temporary ureteral catheter (TU) in group A
Number of subjects: 60

Group type: COMPARATOR
Intervention: Only temporary ureteral catheter (TU) in group B
Number of subjects: 60

Group type: COMPARATOR
Intervention: Only indwelling ureteral catheter (IU) in group C
Number of subjects: 60
Study: 14712889

Group type: EXPERIMENTAL
Intervention: Topical brimonidine 0.2% b.d. (n = 90)
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Topical dorzolamide 2% b.d. (n=91)
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Topical latanoprost 0.005% o.d. (n = 91)
Number of subjects: 272

Group type: COMPARATOR
Intervention: Intergroup comparison of efficacy between brimonidine and dorzolamide
Number of subjects: 272

Group type: COMPARATOR
Intervention: Intergroup comparison of efficacy between dorzolamide and latanoprost
Number of subjects: 272

Group type: COMPARATOR
Intervention: Intergroup comparison of efficacy between brimonidine and latanoprost
Number of subjects: 272
Study: 10826223

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 8877678

Group type: EXPERIMENTAL
Intervention: One transdermal delivery system
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Two transdermal delivery systems
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Three transdermal delivery systems
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Two to three transdermal delivery systems
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Standard recommended dose of two transdermal delivery systems
Number of subjects: 12
Study: 1643987

Group type: EXPERIMENTAL
Intervention: Breast preservation therapy
Number of subjects: 1119
Study: 6084978

Group type: EXPERIMENTAL
Intervention: Pygeum africanum extract
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 30022595

Group type: EXPERIMENTAL
Intervention: Botanical face cleanser with hops and willow bark extract and disodium cocoyl glutamate
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard face cleanser with sodium laureth sulfate (SLES)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both cleansers
Number of subjects: 21
Study: 27554662

Group type: EXPERIMENTAL
Intervention: Low-dose CT (120 kVp, 45 mAs)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Standard-dose CT (120 kVp, 100 mAs)
Number of subjects: 135
Study: 25856525

Group type: EXPERIMENTAL
Intervention: Phonological awareness training
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Visually-based reading training (repeated reading of sight words)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Phonology-based reading training (phonics instruction)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (typical readers)
Number of subjects: 30
Study: 24497655

Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy (AT)
Number of subjects: 464

Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 464
Study: 22927772

Group type: EXPERIMENTAL
Intervention: Pharmacogenetic-based warfarin dosing algorithm (based on CYP2C9 and VKORC1 genotypes)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (2.5mg/d for 3 days, then adjusted to INR)
Number of subjects: 101
Study: 19589291

Group type: EXPERIMENTAL
Intervention: Melatonin and Sulodexide
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Melatonin alone
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (no therapy)
Number of subjects: 102
Study: 18076560

Group type: EXPERIMENTAL
Intervention: Insecticide-treated net (ITN) use
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: Malaria parasitaemia
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: Any anaemia (haemoglobin < 11 g/dl)
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: Moderate anaemia (haemoglobin < 8 g/dl)
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: Demographic and medical factors
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: Hospitalization due to malaria
Number of subjects: 685
Study: 12750107

Group type: EXPERIMENTAL
Intervention: Superior-hinge flap
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Nasal-hinge flap
Number of subjects: 52
Study: 11090714

Group type: EXPERIMENTAL
Intervention: dTpa
Number of subjects: 548

Group type: EXPERIMENTAL
Intervention: pa
Number of subjects: 548

Group type: COMPARATOR
Intervention: Td
Number of subjects: 548

Group type: EXPERIMENTAL
Intervention: dTpa and pa
Number of subjects: 548

Group type: EXPERIMENTAL
Intervention: dTpa and Td
Number of subjects: 548
Study: 9065681

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study: 8103876

Group type: EXPERIMENTAL
Intervention: Glucose-based ORS solution
Number of subjects: 460
Study: 3713254

Group type: EXPERIMENTAL
Intervention: 360 mg Mg/day (as magnesium citrate tablets)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 30212930

Group type: EXPERIMENTAL
Intervention: Nocturnal hemodialysis (NHD)
Number of subjects: 0
Study: 27494036

Group type: EXPERIMENTAL
Intervention: Sequential arm (SA): induction cisplatin-5fluorouracil followed by 70Gy-RT for responders or total laryngectomy and post-operative RT for non-responders
Number of subjects: 450

Group type: COMPARATOR
Intervention: Alternating arm (AA): cisplatin-5fluorouracil alternated with three 2-week courses of 20Gy-RT for a total dose of 60Gy
Number of subjects: 450
Study: 24608204

Group type: EXPERIMENTAL
Intervention: Modified inferior alveolar nerve block technique
Number of subjects: 109

Group type: COMPARATOR
Intervention: Conventional Halsted technique
Number of subjects: 109
Study: 23069788

Group type: EXPERIMENTAL
Intervention: Criterion-based training on the Endoscopic Sinus Surgery Simulator
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control subjects repeated the surgical procedure twice
Number of subjects: 14

Group type: COMPARATOR
Intervention: Attending surgeons
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Experimental subjects
Number of subjects: 14
Study: 20478035

Group type: EXPERIMENTAL
Intervention: Case management (telephone monitoring and home visits)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 199
Study: 18765484

Group type: EXPERIMENTAL
Intervention: 10 mg/day of aripiprazole
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: 30 mg/day of aripiprazole
Number of subjects: 302

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 302
Study: 15759246

Group type: EXPERIMENTAL
Intervention: Goniometric STCA measurements
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Visual STCA measurements
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Visual STCA and goniometric STCA
Number of subjects: 18
Study: 12909392

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 12
Study: 11198392

Group type: EXPERIMENTAL
Intervention: Circular stapled procedure
Number of subjects: 40

Group type: COMPARATOR
Intervention: Milligan‐Morgan haemorrhoidectomy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 8867350

Group type: EXPERIMENTAL
Intervention: PTFE
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Dacron
Number of subjects: 250
Study: 1858191

Group type: EXPERIMENTAL
Intervention: Automatic blood-pressure registration on a computerized ergometer cycle
Number of subjects: 50

Group type: COMPARATOR
Intervention: Manual blood-pressure registration using a standard mercury sphygmomanometer
Number of subjects: 50
Study: 6357339

Group type: EXPERIMENTAL
Intervention: Proximal gastric vagotomy (PGV)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Truncal vagotomy with antrectomy (TVA)
Number of subjects: 145
Study: 31075675

Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure Therapy (VRET)
Number of subjects: 100

Group type: COMPARATOR
Intervention: In-vivo One-Session Treatment (OST)
Number of subjects: 100
Study: 29606861

Group type: EXPERIMENTAL
Intervention: GFF MDI 14.4/10 μg
Number of subjects: 292

Group type: COMPARATOR
Intervention: GP MDI 14.4 μg
Number of subjects: 292

Group type: COMPARATOR
Intervention: FF MDI 10 μg
Number of subjects: 292
Study: 27913559

Group type: EXPERIMENTAL
Intervention: 1 year of supervised, centre-based heavy resistance training
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: home-based moderate intensity resistance training
Number of subjects: 450

Group type: COMPARATOR
Intervention: habitual physical activity (control)
Number of subjects: 450
Study: 25083017

Group type: EXPERIMENTAL
Intervention: Three nights of portable sleep monitoring (3N-PM)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Polysomnography (PSG)
Number of subjects: 56
Study: 22790008

Group type: EXPERIMENTAL
Intervention: i.v. ketamine (bolus at induction, continuous infusion during surgery and first 48 hours postoperatively)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: i.v. ketamine
Number of subjects: 60

Group type: COMPARATOR
Intervention: i.v. placebo (saline solution under the same infusion modalities)
Number of subjects: 60

Group type: COMPARATOR
Intervention: i.v. placebo
Number of subjects: 60
Study: 20307799

Group type: EXPERIMENTAL
Intervention: Buprenorphine-naloxone for short-term opioid detoxification
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 17359515

Group type: EXPERIMENTAL
Intervention: Mobile phone RF exposure
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sham RF exposure
Number of subjects: 17
Study: 16283835

Group type: EXPERIMENTAL
Intervention: Adherence enhancement program
Number of subjects: 85

Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 85
Study: 12040967

Group type: EXPERIMENTAL
Intervention: Pitavastatin 1 mg/day or more
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pitavastatin 1 mg/day to 4 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pitavastatin
Number of subjects: 0
Study: 12799977

Group type: EXPERIMENTAL
Intervention: Low-energy shock-wave therapy (3000 impulses of 0.08 mJ/mm(2))
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control group (30 impulses of 0.08 mJ/mm(2))
Number of subjects: 2
Study: 7622270

Group type: EXPERIMENTAL
Intervention: Acidic syndet bar
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional soap bar
Number of subjects: 120
Study: 1699337

Group type: EXPERIMENTAL
Intervention: Pulmonary tuberculosis patients
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Treatment for pulmonary tuberculosis
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Kuwaiti environment exposure
Number of subjects: 65
Study: 6451422

Group type: EXPERIMENTAL
Intervention: Anticholinergic drugs
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Mast-cell stabilizing cromoglycate
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: beta 2-Sympathomimetic drugs
Number of subjects: 35
Study: 30968326

Group type: EXPERIMENTAL
Intervention: LM-Supreme™ (LM-S)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Endotracheal tube (ETT)
Number of subjects: 100
Study: 31040642

Group type: EXPERIMENTAL
Intervention: Choline alfoscerate tablet (1,200 mg, 400 mg × three doses)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Soft gelatin capsule (Gliatilin®) (1,200 mg, 400 mg × three doses)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Choline alfoscerate tablet vs Soft gelatin capsule
Number of subjects: 50
Study: 28472284

Group type: EXPERIMENTAL
Intervention: Individual-based behavioral intervention
Number of subjects: 688

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 688
Study: 25748830

Group type: EXPERIMENTAL
Intervention: Egg breakfast
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bagel breakfast
Number of subjects: 0